|
 |
Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease
TW Ho, AP Ho, BR Chaitman... - ... : The Journal of ..., 2012 - Wiley Online Library Objective.To evaluate the efficacy of telcagepant in patients with migraine and coronary artery disease. Background.Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular ... [HTML]
From the Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA (T.W. Ho, A.P. Ho, J. Kost, X. Fan, K. Fei, L. Beebe, and C. Lines); St. Louis University School of Medicine, St. Louis, MO, USA (B.R. Chaitman); Headache Care Center, Clarksville, TN, USA (C. Johnson); Houston Headache Clinic Neurology, Houston, TX, USA (N.T. Mathew); Swedish Headache Center, Seattle, WA, USA (S.K. Aurora); Vanderbilt University School of Medicine, Nashville, TN, USA (J.L. Brandes); Duke University Medical Center, Durham, NC, USA (M.W. Krucoff).
More Details:
Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease |
|
|
